ArticleCell death & disease2013

Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma.

G M Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.